Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Zhang, Dawei ^a   Cao, Liangqi ^a   Li, Yue ^a   Lu, Haiwu ^a   Yang, Xuewei ^a   Xue, Ping ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial to mesenchymal transition; Gli2; Hepatocellular carcinoma; Prognosis

Indexed keywords

NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR GLI2; UVOMORULIN; VIMENTIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; DISEASE FREE SURVIVAL; ENCAPSULATION; FEMALE; GENE OVEREXPRESSION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84872970167     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-25     Document Type: Article

References (50)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003, 362:1907-1917. 10.1016/S0140-6736(03)14964-1, 14667750.
2. Page JM, Harrison SA. NASH and HCC. Clin Liver Dis 2009, 13:631-647. 10.1016/j.cld.2009.07.007, 19818310.
3. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
4. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
5. Hubert C, Sempoux C, Rahier J, et al. Prognostic risk factors of survival after resection of hepatocellular carcinoma. Hepatogastroenterology 2007, 54:1791-1797.
6. Sherman M. Recurrence of hepatocellular carcinoma. N Engl J Med 2008, 359:2045-2047. 10.1056/NEJMe0807581, 18923166.
7. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001, 15:3059-3087. 10.1101/gad.938601, 11731473.
8. Ruizi Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002, 2:361-372. 10.1038/nrc796, 12044012.
9. Lum L, Beachy PA. The Hedgehog response network: sensors, switches, and routers. Science 2004, 304:1755-1759. 10.1126/science.1098020, 15205520.
10. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851. 10.1038/nature01972, 14520411.
11. Ji J, Kump E, Wernli M, et al. Gene silencing of transcription factor Gli2 inhibits basal cell carcinomalike tumor growth in vivo. Int J Cancer 2008, 122:50-56. 10.1002/ijc.23023, 17721996.
12. Kubo M, Nakamura M, Tasaki A, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004, 64:6071-6074. 10.1158/0008-5472.CAN-04-0416, 15342389.
13. Thayer SP, di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003, 425:851-856. 10.1038/nature02009, 14520413.
14. Thiyagarajan S, Bhatia N, Reagan-Shaw S, et al. Role of GLI2 transcription factor in growth and tumorigenicity of prostate cells. Cancer Res 2007, 67:10642-10646. 10.1158/0008-5472.CAN-07-2015, 2653855, 18006803.
15. Velcheti V, Govindan R. Hedgehog signaling pathway and lung cancer. J Thorac Oncol 2007, 2:7-10. 10.1097/JTO.0b013e31802c0276, 17410003.
16. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009, 361:1164-1172. 10.1056/NEJMoa0905360, 19726763.
17. Katoh Y, Katoh M. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). Int J Mol Med 2008, 22:271-275.
18. He HC, Chen JH, Chen XB, et al. Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res 2012, 18:349-355. 10.1007/s12253-011-9451-2, 21861243.
19. Liao X, Siu MK, Au CW, et al. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 2009, 30:131-140.
20. Mori Y, Okumura T, Tsunoda S, et al. Gli-1 expression is associated with lymph node metastasis and tumor progression in esophageal squamous cell carcinoma. Oncology 2006, 70:378-389. 10.1159/000098111, 17179732.
21. ten Haaf A, Bektas N, von Serenyi S, et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. BMC Cancer 2009, 9:298-310. 10.1186/1471-2407-9-298, 2753634, 19706168.
22. Xu M, Li X, Liu T, et al. Prognostic value of hedgehog signaling pathway in patients with colon cancer. Med Oncol 2012, 29:1010-6. 10.1007/s12032-011-9899-7, 21424326.
23. Yan M, Wang L, Zuo H, et al. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma. Oral Oncol 2011, 47:504-509. 10.1016/j.oraloncology.2011.03.027, 21536478.
24. Ikram MS, Neill GW, Regl G, et al. GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J Invest Dermatol 2004, 122:1503-1509. 10.1111/j.0022-202X.2004.22612.x, 15175043.
25. Cheng WT, Xu K, Tian DY, et al. Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol 2009, 34:829-836.
26. Kim Y, Yoon JW, Xiao X, et al. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. Cancer Res 2007, 67:3583-3593. 10.1158/0008-5472.CAN-06-3040, 17440069.
27. Patil MA, Zhang J, Ho C, et al. Hedgehog signaling in human hepatocellular carcinoma. Cancer Biol Ther 2006, 5:111-117. 10.4161/cbt.5.1.2379, 16397407.
28. Sicklick JK, Li YX, Jayaraman A, et al. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis. Carcinogenesis 2006, 27:748-757.
29. Zhang D, Liu J, Wang Y, et al. ShRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis. J Cell Biochem 2011, 112:3140-3150. 10.1002/jcb.23240, 21695716.
30. Dai DL, Martinka M, Li G, et al. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol 2005, 23:1473-1482. 10.1200/JCO.2005.07.168, 15735123.
31. Wang Y, Dai DL, Martinka M, et al. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Clin Cancer Res 2007, 13:4111-4116. 10.1158/1078-0432.CCR-07-0408, 17634537.
32. Eichberger T, Sander V, Schnidar H, et al. Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. Genomics 2006, 87:616-632. 10.1016/j.ygeno.2005.12.003, 16434164.
33. Grachtchouk V, Grachtchouk M, Lowe L, et al. The magnitude of hedgehog signaling activity defines skin tumor phenotype. EMBO J 2003, 22:2741-2751. 10.1093/emboj/cdg271, 156767, 12773389.
34. Kump E, Ji J, Wernli M, et al. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Oncogene 2008, 27:3856-3864. 10.1038/onc.2008.5, 18264131.
35. Regl G, Kasper M, Schnidar H, et al. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res 2004, 64:7724-7731. 10.1158/0008-5472.CAN-04-1085, 15520176.
36. Fulda S, Meyer E, Debatin KM. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 2002, 21:2283-2294. 10.1038/sj.onc.1205258, 11948412.
37. Jin CY, Park C, Moon SK, et al. Genistein sensitizes human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by enhancing Bid cleavage. Anticancer Drugs 2009, 20:713-722. 10.1097/CAD.0b013e32832e8998, 19617819.
38. Okano H, Shiraki K, Inoue H, et al. Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma. Lab Invest 2003, 83:1033-1043. 10.1097/01.LAB.0000079328.76631.28, 12861043.
39. Lin M, Guo LM, Liu H, et al. Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma. Histol Histopathol 2010, 25:1269-1275.
40. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002, 21:3241-3246. 10.1038/sj.onc.1205416, 12082640.
41. Ramis-Conde I, Drasdo D, Anderson AR, et al. Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: a multiscale approach. Biophys J 2008, 95:155-165. 10.1529/biophysj.107.114678, 2426623, 18339758.
42. Zheng X, Yao Y, Xu Q, et al. Evaluation of glioma-associated oncogene 1 expression and its correlation with the expression of sonic hedgehog, E-cadherin and S100a4 in human hepatocellular carcinoma. Mol Med Report 2010, 3:965-970.
43. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005, 132:3151-3161. 10.1242/dev.01907, 15983400.
44. Castro Alves C, Rosivatz E, Schott C, et al. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulat ion of E-cadherin. J Pathol 2007, 211:507-515. 10.1002/path.2138, 17299729.
45. Katoh M. Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 2005, 27:1677-1683.
46. Lee JM, Dedhar S, Kalluri R, et al. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981. 10.1083/jcb.200601018, 2063755, 16567498.
47. Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol 2002, 161:1881-1891. 10.1016/S0002-9440(10)64464-1, 1850763, 12414534.
48. Zheng X, Rumie Vittar NB, Gai X, et al. The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism. PLoS One 2012, 7:e49581. 10.1371/journal.pone.0049581, 3501480, 23185371.
49. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890. 10.1016/j.cell.2009.11.007, 19945376.
50. Alexaki VI, Javelaud D, Van Kempen LC, et al. GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst 2010, 102:1148-1159. 10.1093/jnci/djq257, 2914763, 20660365.